Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three distinct medications: - Sertraline: A selective serotonin reuptake inhibitor (SSRI) antidepressant - Penicillin: A beta-lactam antibiotic - Azithromycin: A macrolide antibiotic This combination presents several potential drug interactions that require medical supervision. The most significant concern is the risk of QT interval prolongation when combining sertraline with azithromycin, which could potentially trigger ventricular arrhythmias of the torsades de pointes type[1][7]. Additionally, sertraline has demonstrated antimicrobial properties that may interact with the antibiotic effects of penicillin and azithromycin[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sertraline + penicillin + azithromycin.